Trial Profile
Effect of Intravenous Alpha-1 Antitrypsin on Preserving Beta-cell Function in New-onset Type 1 Diabetes Mellitus.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RETAIN
- 14 Jan 2015 According to the ClinicalTrials.gov record, status changed from suspended to discontinued.
- 14 Jan 2015 According to the ClinicalTrials.gov record, status changed from suspended to discontinued.
- 25 Feb 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov(NCT01183468).